Blood Cancer | sciencenewsnet.in

New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma

The National Comprehensive Cancer Network announces publication of new NCCN Guidelines for Pediatric Hodgkin Lymphoma, one of the most curable forms of pediatric cancer. They synthesize the latest evidence and expert-consensus to make sure every child receives appropriate, but not excessive, treatment.

Announcement

New NCCN Resource for Understanding Childhood Leukemia

September 23, 2020 sarah Jonas Acute Lymphoblastic Leukemia, Blood Cancer, Childhood Cancer, Childhood Cancer Awareness Month, Hematologic Cancers, hematologic malignancies, Leukemia, National Comprehensive Cancer Network, NCCN, NCCN Foundation, nccn guidelines, NCCN Guidelines for Patients, Pediatric Acute Lymphoblastic Leukemia, pediatric acute lymphoblastic leukemia (ALL), Pediatric ALL, pediatric leukemia

NCCN publishes a new patient and caregiver resource focused on a childhood cancer type. Free NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia (ALL) shares the latest expert advice for treating infants, children, and adolescents with the most common pediatric malignancy.

Research Results

Roswell Park Study: Delaying Antiviral Treatment May Boost Immunity in Stem Cell Transplant Recipients

August 25, 2020 sarah Jonas Blood Cancer, BMT, Bone Marrow Transplant, Cancer, Cellular Therapy, Organ Transplant, Stem Cell Transplant

Patients who develop cytomegalovirus infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, a team from Roswell Park reports in the journal Biology of Blood and Marrow Transplantation.

Research Results

2 immunotherapies merged into single, more effective treatment

July 23, 2020 sarah Jonas Blood Cancer, Cancer, CAR T cell therapy, Immunotherapy, Leukemia, Natural Killer Cells

Researchers at Washington University School of Medicine in St. Louis have combined two immunotherapy strategies into a single therapy and found, in studies in human cells and in mice, that the two together are more effective than either alone in treating certain blood cancers, such as leukemia.

Research Results

Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia

May 12, 2020 sarah Jonas Blood Cancer, Leukaemia, New Jersey, Rutgers Univeristy

Researchers from Rutgers Cancer Institute of New Jersey along with collaborators from Princeton University identify a new drug that has therapeutic effect against the aggressive hematological disease T-cell acute lymphoblastic leukemia.

Announcement

IU cancer researcher earns $1.6 million NCI grant for multiple myeloma bone disease therapies

May 12, 2020 sarah Jonas Blood Cancer, Bone Disease, Cancer, molecule, multiple myelmoma

David Roodman is leading research to investigate a molecule that could repair bone, decrease tumors and improve outcomes for multiple myeloma patients on specific targeted therapies.

Research Results

Researchers Identify Potential Formula for Blood Cancer Vaccine

December 19, 2019 sarah Jonas 0 Comments Blood Cancer, Icahn School of Medicine at Mount Sinai, Immunotherapy, Mount Sinai Health System, Research, Study, Vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.

Research Results

Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug

November 12, 2019 sarah Jonas 0 Comments Blood Cancer, Blood Pressure, Cancer, Diabetes, Endocrinology, Health, Hormones, Icahn School of Medicine at Mount Sinai, Medication, Medicine, Metabolism, metabolism and cancer, Mount Sinai Health System, Obesity, Research, Science, scientific reports, Treatment, Weight Gain

Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure